MEDX Horizon Kinetics Medical ETF
Listed Funds Trust - Horizon Kinetics Medical ETF is an exchange traded fund launched by Listed Funds Trust. The fund is managed by Horizon Kinetics Asset Management LLC. The fund invests in public equity markets of global region. It invests in stocks of companies operating across healthcare, healthcare equipment and services, healthcare equipment and supplies, healthcare equipment, medical equipment, surgical and laboratory sterilizers, healthcare providers and services, health care services, medical laboratory services, medical research laboratory services, pharmaceuticals, biotechnology and life science sectors. It invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to benchmark the performance of its portfolio against the S&P 500 TR Index. Listed Funds Trust - Horizon Kinetics Medical ETF was formed on September 30, 1999 and is domiciled in the United States.
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| MEDX | +7.1% | +6.2% | +14.2% | +17.5% | +13.8% | — |
| Equity average (4725 funds) | -2.2% | -4.7% | +3008.3% | +1886.0% | +15.1% | +2.6% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$3K net.
Holdings · as of Nov 13, 2026
| # | Holding | Weight |
|---|---|---|
| 1 | LLY Eli Lilly & Co | 21.30% |
| 2 | ABBV AbbVie Inc | 10.06% |
| 3 | MEDX US BANK MMDA - USBGFS 7 06/01/2031 | 7.71% |
| 4 | NVS Novartis AG | 6.84% |
| 5 | JNJ Johnson & Johnson | 6.06% |
| 6 | AMGN Amgen Inc | 4.90% |
| 7 | ALKS Alkermes PLC | 4.81% |
| 8 | AZN AstraZeneca PLC | 4.70% |
| 9 | MRK Merck & Co Inc | 4.39% |
| 10 | BMY Bristol-Myers Squibb Co | 4.19% |
| 11 | BIIB Biogen Inc | 3.47% |
| 12 | PFE Pfizer Inc | 3.32% |
| 13 | REGN Regeneron Pharmaceuticals Inc | 3.05% |
| 14 | GSK GSK PLC | 2.51% |
| 15 | CRSP CRISPR Therapeutics AG | 2.00% |
| 16 | ALNY Alnylam Pharmaceuticals Inc | 1.73% |
| 17 | IONS Ionis Pharmaceuticals Inc | 1.52% |
| 18 | REPL Replimune Group Inc | 1.41% |
| 19 | BEAM Beam Therapeutics Inc | 1.03% |
| 20 | SDZNY Sandoz Group AG | 0.89% |
| 21 | GALT Galectin Therapeutics Inc | 0.75% |
| 22 | NTLA Intellia Therapeutics Inc | 0.68% |
| 23 | HLN Haleon PLC | 0.57% |
| 24 | VNDA Vanda Pharmaceuticals Inc | 0.46% |
| 25 | GEHC GE HealthCare Technologies Inc | 0.35% |
| 26 | VTRS Viatris Inc | 0.33% |
| 27 | EDIT Editas Medicine Inc | 0.30% |
| 28 | BCYC Bicycle Therapeutics PLC | 0.22% |
| 29 | PACB Pacific Biosciences of California Inc | 0.10% |
| 30 | ALLO Allogene Therapeutics Inc | 0.07% |
| 31 | LTRN Lantern Pharma Inc | 0.06% |
| 32 | DCOY Decoy Therapeutics Inc | 0.00% |
Sector breakdown
Country breakdown
Distributions
| Date | Per unit |
|---|---|
| Dec 23, 2025 | $0.4088 |
| Dec 24, 2024 | $0.5071 |
| Dec 27, 2023 | $1.6423 |
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in MEDX in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 13, 2026. This is historical data, not investment advice. Report a data error